-
Predicting Major Bleeding During Extended Anticoagulation
2026-09-09
This prospective multinational cohort study evaluated bleeding-risk prediction during extended anticoagulation after unprovoked or weakly provoked venous thromboembolism. Modified ACCP, VTE-BLEED, and HAS-BLED scores performed well, while the simpler CHAP model used continuous creatinine, hemoglobin, age, and antiplatelet-use variables but requires external validation.
-
Cell Cycle Assay Kit: GANT61 Workflow
2026-09-09
Learn how to use the Cell Cycle Assay Kit (Catalog No. K2263) to connect DNA-content changes with proliferation, arrest, and apoptosis in ALK-positive lymphoma models. This workflow emphasizes practical flow cytometry gating, RNase A control, sub-G1 interpretation, and orthogonal validation of GANT61 mechanism.
-
Placental Exosomal miR-519d-3p in Preeclampsia
2026-09-08
The reference study connects elevated miR-519d-3p in placenta-derived exosomes with T-cell proliferation, reduced apoptosis, and a Th17-skewed immune phenotype in preeclampsia. Its exosome–trophoblast–T-cell model provides a mechanistic framework for studying maternal–fetal immune tolerance, while viability and DNA-content assays can help validate cell-state changes in related workflows.
-
Cy5-UTP: From RNA Labeling to Assay Design
2026-09-08
Cy5-UTP enables direct fluorescent RNA probe synthesis, but its greatest value depends on how labeling density, spectral detection, and RNA function are balanced. This guide connects Cyanine 5-uridine triphosphate chemistry with mechanistic insights from U3 snoRNA–DDX21 research.
-
Geneticin: From Cell Selection to Translational Control
2026-09-07
Geneticin and G418 Sulfate are more than routine selection reagents: they connect engineered-cell survival, ribosomal protein synthesis inhibition, and antiviral assay design. This thought-leadership analysis shows how translational researchers can use G-418 while separating selection biology from treatment effects and interpreting engineered-cell data with greater rigor.
-
MK-8745: From Aurora A Biology to Assay Design
2026-09-07
Explore how MK-8745, a potent and selective Aurora A inhibitor, connects mitotic disruption with apoptosis, lymphoma, and xenograft research. This mechanism-first guide translates retinoblastoma findings into practical decisions for model selection, controls, and assay interpretation.
-
DAPI Nuclear Stain Solution: Practical Guide
2026-09-05
DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution, SKU K2402, provides a ready-to-use blue-fluorescent DNA stain for nuclear visualization, cell viability assessment, and apoptosis-related nuclear analysis. It is best suited to fixed or membrane-compromised samples examined by fluorescence microscopy or flow cytometry, rather than routine imaging of intact live cells.
-
Annexin V-PE Reagent for CAR-T Cell Death Assays
2026-09-04
Annexin V-PE Reagent provides a rapid, phosphatidylserine-based readout for comparing CAR-T cytotoxicity, fratricide, and treatment-induced apoptosis. Its flow cytometry and microscopy compatibility helps connect structural binder optimization with practical cell death measurements.
-
Annexin V-PE and CD38 CAR-T Apoptosis
2026-09-04
Structural studies of CD38 CAR binders show why epitope geometry and calibrated affinity can shape cytotoxicity, enzymatic inhibition, and fratricide. This article connects those design principles to Annexin V-PE-based phosphatidylserine externalization detection, offering a practical framework for translating molecular engineering into interpretable cell-death measurements.
-
AO/PI Staining Solution for Podocyte Viability
2026-09-03
Build a more reliable fluorescent cell viability assay for high-glucose podocytes, renal research, and impurity-prone samples. This guide shows how AO/PI Staining Solution supports live/dead cell discrimination, standardized fluorescence-based cell counting, and better interpretation of phillygenin experiments.
-
Spirocyclic POM Analogues Target MmpL3 in TB
2026-09-03
A 2024 Bioorganic Chemistry study developed spirocyclic phenyl oxazole methyl analogues and identified compound 5c as a potent inhibitor of Mycobacterium tuberculosis, including drug-resistant clinical isolates. Phenotypic screening, spontaneous mutant generation, ADME and pharmacokinetic profiling, cytotoxicity testing, and molecular docking connected the compound series to the essential transporter MmpL3 and established a foundation for further anti-tubercular optimization.
-
BMPSB4 Activates Autophagy in Corticotroph PitNETs
2026-09-02
This 2024 study identifies BMPSB4 as a pharmacological agonist of reduced BMP4 signaling in corticotroph pituitary neuroendocrine tumors. Using human tumor data, cell-based pathway assays, autophagy analyses, and an in vivo model, the authors link BMP4/SMAD1/5/9 activation to autophagy-mediated tumor inhibition and reduced ACTH-related endocrine abnormalities.
-
Nintedanib: An ATRX-Stratified Research Strategy
2026-09-02
Nintedanib (BIBF 1120) is more than a broad-spectrum angiokinase inhibitor: it can serve as a probe for biomarker-defined receptor tyrosine kinase vulnerabilities. This article translates ATRX-deficient glioma findings into rigorous assay design while defining the boundaries between oncology and fibrosis research.
-
Sulfo-NHS-SS-Biotin for Reliable Cell Assays
2026-09-01
Learn how Sulfo-NHS-SS-Biotin (SKU A8005) supports controlled cell-surface protein labeling, reversible affinity workflows, and interpretation of viability or cytotoxicity experiments. This scenario-based guide covers reagent compatibility, fresh-solution handling, DTT cleavage, controls, and practical product-selection criteria.
-
Genetic Inflammation Networks in Mouse Brain
2026-09-01
Xiong et al. develop a high-throughput bulk RNA-seq framework for comparing inflammatory states across genetically heterogeneous, ENU-mutagenized mouse brains. The study shows that mutations in six CNS disease-associated genes produce distinguishable microglial and astrocytic responses, providing a practical strategy for identifying modular regulators of neuroimmune homeostasis.